Hap Trading, LLC Arbutus Biopharma Corp Call Options Transaction History

Hap Trading, LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2022 Feb 14, 2023	BUY	$1.91 - $2.85 $23,493 - $35,055	12,300 New	12,300 $0
Q2 2022 Aug 12, 2022	SELL	$1.98 - $3.17 $19,800 - $31,700	-10,000 Reduced 34.6%	18,900 $3,000
Q1 2022 May 12, 2022	SELL	$2.42 - $3.98 $92,928 - $152,832	-38,400 Reduced 57.06%	28,900 $13,000
Q4 2021 Feb 14, 2022	BUY	$3.11 - $4.61 $121,601 - $180,251	39,100 Added 138.65%	67,300 $35,000
Q3 2021 Nov 10, 2021	BUY	$2.65 - $4.62 $27,560 - $48,048	10,400 Added 58.43%	28,200 $27,000
Q2 2021 Aug 11, 2021	BUY	$2.5 - $3.51 $8,750 - $12,285	3,500 Added 24.48%	17,800 $7,000
Q1 2021 May 14, 2021	SELL	$3.14 - $4.84 $36,424 - $56,144	-11,600 Reduced 44.79%	14,300 $8,000
Q4 2020 Feb 16, 2021	BUY	$2.76 - $4.97 $31,739 - $57,155	11,500 Added 79.86%	25,900 $12,000
Q3 2020 Nov 13, 2020	BUY	$1.75 - $6.2 $25,200 - $89,280	14,400 New	14,400 $8,000

138

95.4M

3.44M

377K

Ticker ABUS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 149,951,008
Market Cap $591M
Description
Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.